CIK: 0001826434 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value ($000): $435,052 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| JNJ | JOHNSON & JOHNSON | 302,831 | $56,151 | 12.9% | $169.51 | 0.0% | COM | 478160104 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 122,187 | $51,222 | 11.8% | $336.31 | 0.0% | COM | 91307C102 |
| MRK | MERCK & CO INC | 446,874 | $37,506 | 8.6% | $81.01 | 0.0% | COM | 58933Y105 |
| AXSM | AXSOME THERAPEUTICS INC | 292,137 | $35,480 | 8.2% | $101.43 | +11.1% | COM | 05464T104 |
| ASND | ASCENDIS PHARMA A/S | 174,829 | $34,758 | 8.0% | $173.58 | — | SPONSORED ADR | 04351P101 |
| VERA | VERA THERAPEUTICS INC | 1,190,207 | $34,587 | 8.0% | $24.12 | -4.1% | CL A | 92337R101 |
| ARGX | ARGENX SE | 43,411 | $32,018 | 7.4% | $507.27 | — | SPONSORED ADR | 04016X101 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 67,706 | $31,054 | 7.1% | $267.97 | +39.2% | COM | 558868105 |
| SLNO | SOLENO THERAPEUTICS INC | 450,585 | $30,460 | 7.0% | $60.96 | +21.6% | COM | 834203309 |
| ABBV | ABBVIE INC | 89,621 | $20,751 | 4.8% | $189.97 | +6.3% | COM | 00287Y109 |
| KRRO | KORRO BIO INC | 337,764 | $16,176 | 3.7% | $33.68 | -34.1% | COM | 500946108 |
| XENE | XENON PHARMACEUTICALS INC | 366,102 | $14,699 | 3.4% | $35.22 | 0.0% | COM | 98420N105 |
| — | AVADEL PHARMACEUTICALS PLC | 724,859 | $11,069 | 2.5% | $8.85 | — | COM SHS | G29687103 |
| STVN | STEVANATO GROUP S P A | 332,912 | $8,572 | 2.0% | $24.68 | 0.0% | ORD SHS | T9224W109 |
| DNTH | DIANTHUS THERAPEUTICS INC | 182,867 | $7,196 | 1.7% | $25.56 | 0.0% | COM | 252828108 |
| TARS | TARSUS PHARMACEUTICALS INC | 119,260 | $7,088 | 1.6% | $45.00 | +9.4% | COM | 87650L103 |
| PRAX | PRAXIS PRECISION MEDICINES I | 75,986 | $4,027 | 0.9% | $50.40 | -3.8% | COM NEW | 74006W207 |
| BHVN | BIOHAVEN LTD | 149,179 | $2,239 | 0.5% | $17.82 | -18.3% | COM | G1110E107 |